BlackRock Health Sciences Term Trust (NYSE:BMEZ) Plans $0.11 Monthly Dividend

BlackRock Health Sciences Term Trust (NYSE:BMEZ) announced a monthly dividend on Friday, February 27th. Stockholders of record on Monday, June 15th will be given a dividend of 0.11 per share on Tuesday, June 30th. This represents a c) annualized dividend and a dividend yield of 9.1%. The ex-dividend date is Monday, June 15th.

BlackRock Health Sciences Term Trust Stock Performance

Shares of NYSE BMEZ opened at $14.52 on Friday. The company has a 50 day simple moving average of $14.29 and a 200-day simple moving average of $14.74. BlackRock Health Sciences Term Trust has a 1 year low of $13.67 and a 1 year high of $15.80.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

A number of institutional investors and hedge funds have recently modified their holdings of BMEZ. Bank of America Corp DE raised its stake in BlackRock Health Sciences Term Trust by 4.1% in the third quarter. Bank of America Corp DE now owns 1,535,091 shares of the company’s stock valued at $22,136,000 after buying an additional 61,105 shares in the last quarter. Invesco Ltd. raised its position in shares of BlackRock Health Sciences Term Trust by 42.7% during the 3rd quarter. Invesco Ltd. now owns 929,121 shares of the company’s stock worth $13,398,000 after acquiring an additional 278,024 shares in the last quarter. Rivernorth Capital Management LLC boosted its holdings in BlackRock Health Sciences Term Trust by 24.8% in the first quarter. Rivernorth Capital Management LLC now owns 809,196 shares of the company’s stock valued at $11,620,000 after purchasing an additional 160,629 shares in the last quarter. Saba Capital Management L.P. purchased a new position in BlackRock Health Sciences Term Trust in the first quarter valued at approximately $10,907,000. Finally, Lazard Asset Management LLC raised its holdings in BlackRock Health Sciences Term Trust by 64.2% during the first quarter. Lazard Asset Management LLC now owns 621,604 shares of the company’s stock worth $8,926,000 after purchasing an additional 243,054 shares in the last quarter.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.